Question 1

What is the catalog number for TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat)?

Accepted Answer

The catalog number for TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat) is 46276126.

Question 2

What sizes are available for TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat)?

Accepted Answer

TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat) in stock?

Accepted Answer

TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

TBCC CRISPRa sgRNA lentivector (set of three targets)(Rat)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Histone H1 (HH1/957), CF488A conjugate, 0.1mg/mL

CD46 (122.2), CF405S conjugate, 0.1mg/mL

Anti-Sumo 1/SUMO1 Antibody

Anti-SDHB Antibody Picoband®, Dylight550 Conjugate

Calreticulin Recombinant Rabbit Monoclonal Antibody [SU37-03]

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 0.2mg/mL